⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIST News
Milestone Pharmaceuticals Inc. Common Shares
Milestone® Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
globenewswire.com
MIST
Singular Research Emerging Growth & Value Leaders Webinar Thursday, February 19, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RAIN
FLNT
VTIX
MIST
ACU
LRN
Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
globenewswire.com
MIST
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MIST
Industrial Radiography Industry Research Report 2026 - Global Market Size, Share, Trends, Opportunity, and Forecast, 2021-2025 & 2026-2031
globenewswire.com
BKR
OII
MIST
Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
globenewswire.com
MIST
El equipo de Mistral y UVision anuncia la selección de HERO-90 para el programa LASSO del ejército de EE. UU. USA - español USA - English
prnewswire.com
MIST
Mistral and UVision Team Announces HERO-90 Selection for U.S. Army's LASSO Program
prnewswire.com
MIST
Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency
globenewswire.com
MIST
Oil and Gas NDT and Inspection Market worth $6.20 billion by 2030 - Exclusive Report by MarketsandMarkets™
prnewswire.com
BKR
MIST